Journal article · 2001 · Open access
Pharmacogenetics and pharmacogenomics
British Journal of Clinical Pharmacology, 52(4), 345–347 · Published 1 October 2001 · DOI 10.1046/j.0306-5251.2001.01498.x
In brief
“Pharmacogenetics and pharmacogenomics” is a 2001 journal article by Munir Pirmohamed, published in British Journal of Clinical Pharmacology. OpenAlex counts 241 citations as of 21 November 2026, which puts it in the top 5% of works published in 2001 by citations. It is open access: the full text is free to read at British Journal of Clinical Pharmacology.
- Citations
- 241
- Most cited in
- 2021 (23)
- Field-weighted impact
- 2.62
- References
- 28
- Authors
- 1
Abstract
Pharmacogenetics has been defined as the study of variability in drug response due to heredity [1]. More recently, with the fashion for adding the suffix ‘… omics’ to areas of research, the term ‘pharmacogenomics’ has been introduced. While the former term is largely used in relation to genes determining drug metabolism, the latter is a broader based term that encompasses all genes in the genome that may determine drug response [2]. The distinction however, is arbitrary and both terms can be used interchangeably. Over the last 12–18 months, a large number of articles have appeared on pharmacogenomics in various journals. In addition, three new journals with the term ‘pharmacogenomics’ in their title have been launched (Pharmacogenomics, The American Journal of Pharmacogenomics and The Pharmacogenomics Journal). This is because pharmacogenomics is viewed as a highly important area for improving drug therapy and prescribing in the future. Whether this promise is fulfilled and to what extent will only become evident with time. In this issue of the Journal, we start a new review series of articles concentrating on the area of pharmacogenetics/pharmacogenomics to provide readers with the state of the art in relevant aspects of this area, which we hope will help them assess for themselves the importance (or not) of this area with respect to both their clinical practice and research. The history of pharmacogenetics stretches as far back as 510 b.c. when Pythagoras noted that ingestion of fava beans resulted in a potentially fatal reaction in some, but not all, individuals [1]. Since then there have been numerous landmarks (Table 1) that have shaped this field of research, and have led to the current wave of interest. Variation within the human genome is seen about every 500–1000 bases [3]. Although there are a number of different types of polymorphic markers, most attention recently has focused on single nucleotide polymorphisms (SNPs, pronounced snips), and the potential for using these to determine the individual drug response profile. SNPs occur at a frequency of 1% or greater in the population [4]. A consortium between the pharmaceutical industry and charities such as the Wellcome Trust was formed to create a library of 300 000 SNPs; this project was always well ahead of the intended schedule, and has recently resulted in the publication of a SNP map comprising 1.42 million SNPs at an average density of one SNP every 1.9 kilobases [5]. The database is publicly available (http://snp.cshl.org). Theoretically, this could be used to create individual SNP profiles that correlate with individual drug response. Currently…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pirmohamed, M. (2001). Pharmacogenetics and pharmacogenomics. British Journal of Clinical Pharmacology, 52(4), 345–347. https://doi.org/10.1046/j.0306-5251.2001.01498.x
MLA 9
Pirmohamed, Munir. “Pharmacogenetics and pharmacogenomics.” British Journal of Clinical Pharmacology, vol. 52, no. 4, 2001, pp. 345–347. https://doi.org/10.1046/j.0306-5251.2001.01498.x.
Chicago
Pirmohamed, Munir. 2001. “Pharmacogenetics and pharmacogenomics.” British Journal of Clinical Pharmacology 52 (4): 345–347. https://doi.org/10.1046/j.0306-5251.2001.01498.x.
Harvard
Pirmohamed, M. (2001) ‘Pharmacogenetics and pharmacogenomics’, British Journal of Clinical Pharmacology, 52(4), pp. 345–347. doi:10.1046/j.0306-5251.2001.01498.x.
IEEE
M. Pirmohamed, “Pharmacogenetics and pharmacogenomics,” British Journal of Clinical Pharmacology, vol. 52, no. 4, pp. 345–347, 2001, doi: 10.1046/j.0306-5251.2001.01498.x.
BibTeX
@article{pirmohamed2001pharmacogenetics,
title = {{Pharmacogenetics and pharmacogenomics}},
author = {Pirmohamed, Munir},
journal = {British Journal of Clinical Pharmacology},
year = {2001},
volume = {52},
number = {4},
pages = {345--347},
doi = {10.1046/j.0306-5251.2001.01498.x},
url = {https://doi.org/10.1046/j.0306-5251.2001.01498.x}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 6 | |
| 2018 | 19 | |
| 2019 | 14 | |
| 2020 | 22 | |
| 2021 | 23 | |
| 2022 | 14 | |
| 2023 | 16 | |
| 2024 | 22 | |
| 2025 | 14 | |
| 2026 | 12 |
Its field-weighted citation impact is 2.62: it has been cited 2.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenetics
- pharmacogenomics
- drug response variability
- single nucleotide polymorphisms
- genetic polymorphism
- drug metabolism genes
- personalized medicine
- drug prescribing
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Pirmohamed, M. (2001). Pharmacogenetics and pharmacogenomics. British Journal of Clinical Pharmacology, 52(4), 345–347. https://doi.org/10.1046/j.0306-5251.2001.01498.x
How many times has this paper been cited?
241 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at British Journal of Clinical Pharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Munir Pirmohamed.
What is the DOI of this paper?
10.1046/j.0306-5251.2001.01498.x, permanently at https://doi.org/10.1046/j.0306-5251.2001.01498.x. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.